The global Regenerative Artificial Skin Market is expected to be valued at USD 2,185.5 Million in 2022. The rising need for temporary and permanent skin materials in hospitals and clinics is driving the growth of this market. The overall demand for regenerative artificial skin is projected to grow at a CAGR of 9.9% between 2022 and 2032, totaling around USD 5,615.5 Million by 2032.
Skin is the largest organ in the body and one of the most essential organs. Skin serves as a barrier between the outside world and the internal environment of the body. The skin helps to keep the body's moisture level stable. Sweating is the mechanism through which the skin regulates the body's temperature. The skin protects the body by keeping hazardous microorganisms at bay.
The skin has numerous nerve endings, which allow it to respond to heat, pressure, touch, cold, and pain. Skin aids in the creation of Vitamin D, which is essential for appropriate bone and tooth development. Skin is made up of two layers: an epidermal layer and a dermal layer. The epidermal layer is the outer layer that serves as the body's primary barrier against potentially harmful situations.
The dermal layer is the skin layer between the epidermal and subcutaneous layers. Accidental skin burns are becoming more common. Life-threatening skin injuries, traumas, and burns necessitate rapid surgical intervention to repair skin and prevent further consequences. Heat, fire, radiation, or chemicals can all cause skin burns. Skin burns are classified into three levels: first, second, and third-degree burns.
A first-degree burn affects just the outside layer of skin, causing redness, pain, and swelling; a second-degree burn affects both the outer and inner layers of skin and may spread downward into the dermis. Third-degree burn affects all layers of skin as well as the interior organs. Artificial skin is often made of collagen, which is easily absorbed by the body and aids in the regeneration of new skin on the damaged area. Various firms do ongoing research to create new technologies in artificial skin regeneration, such as Avita Medical's autologous spray on skin.
| Data Points | Key Statistics |
|---|---|
| Regenerative Artificial Skin Market Value 2022 | USD 2,185.5 Million |
| Regenerative Artificial Skin Market Projected Value (2032) | USD 5,615.5 Million |
| Regenerative Artificial Skin Market CAGR (2022 to 2032) | 9.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global demand for regenerative artificial skin is projected to increase at a CAGR of 9.9% during the forecast period between 2022 and 2032, reaching a total of USD 5615.5 Million in 2032, according to a report from Future Market Insights (FMI). From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 7%.
The regenerative artificial skin industry is being pushed by reasons such as increased demand for minimally invasive operations, an increase in the prevalence of chronic wounds, and an aging population. Moreover, the growing awareness of the benefits of regenerative artificial skin products among surgeons and patients is also propelling the market forward.
Regenerative artificial skin products are more expensive than typical wound care solutions, which may limit the market's growth. The lack of trained specialists in emerging nations may stymie this market's growth possibilities.
Growing Incidences of Chronic Wounds to Accelerate the Market Growth
Sedentary lifestyles, bad eating habits, and chronic conditions such as obesity and diabetes all contribute to the creation of chronic wounds. As a result of the growing number of patients suffering from diabetes and obesity, the need for quick wound healing has expanded dramatically.
According to the International Diabetes Federation (IDF), 463 million people worldwide have diabetes in 2019, with the figure anticipated to rise to 700 million by 2045. These reasons are expected to drive demand for regenerating artificial skin in the coming years. Furthermore, the significant growth in traumatic injuries and burn cases throughout the world is predicted to boost the future need for regenerating artificial skin.
Principal Consultant
Expensive Surgeries and Drug Delivery to Impede the Market Growth
Expensive surgeries and drug delivery; complete skin treatment; and side effects are predicted to stymie the industry in the near future. In developing nations, the market is likely to be hampered by a lack of understanding of the products and services offered, insufficient medical infrastructure, and limited access to medical facilities.
Rising Occurrence of Chronic Wounds Cases to fuel Market Growth
The said market in North America is expected to accumulate the highest market share of 61.6% in 2022, and the lion’s share of this overall regional market is contributed by the USA. USA's regenerative artificial skin market continues to be a significant market for the global health sector due to the strong presence of industry players that are availing of very advanced and sophisticated treatments for patients around the world.
Furthermore, throughout the projected period, USA domestic market is likely to experience a surging demand for regenerative artificial skin over the coming years. This increase is attributed to reasons such as an increase in chronic wounds as a result of the growing number of chronic illnesses and an increase in the senior population.
For example, according to a 2020 study issued by the Trust for America's Health Organization, the adult obesity rate in the USA is about 42.4%, marking the first time the national percentage has surpassed the 40.0% threshold.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
An Increase in the Frequency of Unintentional Burns to Fuel the Market Growth
The regenerative artificial skin market in Europe is expected to accumulate a market share value of 20.3% in 2022. The strong presence of some of the major market players, as well as the rising use of regenerative skin treatment, is driving the market expansion of regenerative skin treatment in European countries.
Changes in burn management reforms are being made in industrialized nations such as the United Kingdom, which is providing excellent support for the expansion of the regenerative artificial Obesity is a primary cause of chronic wounds because it creates vascular insufficiency. As a result, it is expected to drive the adoption of skin regeneration treatment throughout the forecast period.
The target market in the Asia Pacific is expected to accumulate a significant market share of 15% in the current year, 2022, and is expected to continue to maintain the trend over the forecast period as well. During the forecast period, the Japan regenerative artificial skin market is expected to rise rapidly and is predicted to be one of the market's most profitable segments.
The market in Japan is mostly getting driven by increased public knowledge about skin regeneration treatment. This can also be attributed to an increase in the number of individuals opting for aesthetic operations, an increase in the frequency of unintentional burns, and an increase in the number of people opting for plastic surgery as per capita income rises.
In South Korea, expenditure in the Skin Care category is expected to be around USD 7.85 billion in 2022 and is predicted to expand by 5.72% each year. Moreover, the emergence of a number of new market players sensing the growing opportunities in the use of stem cells for skin generation in the Asia Pacific has strengthened the market than before.
Increasing Drivers, Restraints, Opportunities, and Threats initiatives, coupled with product innovations by market participants, are some of the primary drivers driving South Korea's regenerative artificial skin market growth.
T&R Biofab Company, located in South Korea, for example, obtained a patent for their 3D bio-printing method to make artificial skin in April 2019. The method works by 3D printing dermal and epidermal cells in a porous 3D framework to create a skin with properties comparable to genuine tissue.
Rising Occurrence of Chronic Wounds Cases to fuel Market Growth
The regenerative artificial skin market in North America is expected to accumulate the highest market share of 61.6% in 2022. North America will continue to be a significant market for the regenerative artificial skin market due to deeper market penetration of treatments and the strong presence of industry players.
Throughout the projected period, North America is likely to lead the entire regenerative artificial skin market. The increase is attributed to reasons such as an increase in chronic wounds as a result of the growing number of chronic illnesses and an increase in the senior population. For example, according to a 2020 study issued by the Trust for America's Health Organization, the adult obesity rate in the USA is about 42.4%, marking the first time the national percentage has surpassed the 40.0% threshold.
Obesity is a primary cause of chronic wounds because it creates vascular insufficiency. Poor oxygenation occurs from vascular insufficiency, which causes delays in normal wound healing and even tissue necrosis. As a result, an increase in obesity incidence in this area is expected to drive market development throughout the forecast period.
An Increase in the Frequency of Unintentional Burns to Fuel the Market Growth
The regenerative artificial skin market in the Asia Pacific is expected to accumulate a significant market share of 15% in 2022 and is expected to continue to maintain the trend over the forecast period as well.
The market in Asia Pacific is expected to be driven by increased public knowledge about the use of skin and healthcare products. During the forecast period, the Asia Pacific regenerative artificial skin market is expected to rise rapidly. It is predicted to be one of the market's most profitable segments.
This may be attributed to an increase in the number of individuals opting for aesthetic operations, an increase in the frequency of unintentional burns, and an increase in the number of people opting for plastic surgery as per capita income rises.
Presence of Major Players in the Region to Accelerate Market
The regenerative artificial skin market in Europe is expected to accumulate a market share value of 20.3% in 2022. The strong presence of some of the major market players, as well as the rising use of the processes, is driving market expansion in these areas.
Changes in burn management reforms are being made in industrialized nations such as the United Kingdom, providing excellent support for the expansion of the regenerative artificial skin sector.
Engineered Skin Material Segment to Drive the Regenerative Artificial Skin Market
On the basis of material type, sub-segments including engineered skin material in the worldwide regenerative artificial skin market are predicted to expand in positive traction owing to its instant capabilities of composite skin material and success rate in artificial skin regeneration.
As reported by the American Burn Association, 486,000 people received medical treatment for minor burns in 2015, while 70,000 people were hospitalized for severe skin burns.
Start-ups and their innovations are driving some of the most recent advances in the Regenerative Artificial Skinsector. Let's have a look at some of the primary areas of innovation in this industry:
Several industry players are expanding their product portfolios in the regenerative artificial skin market. Integra Life Sciences Corporation, Mylan N.V., Johnson & Johnson Services, Inc., Smith & Nephew, and Mallinckrodt plc are some of the main companies in the Global regenerative artificial skin market.
Recent Developments:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 9.9% from 2022 to 2032 |
| Market Value in 2022 | USD 2,185.5 Million |
| Market Value in 2032 | USD 5,615.5 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Material Type, End User, Region |
| Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, India, Malaysia, Singapore, Thailand, Australia, New Zealand, GCC Countries, South Africa, Israel |
| Key Companies Profiled | Integra Life Sciences Corporation; Mylan N.V.; Johnson & Johnson Services, Inc.; Smith & Nephew; Mallinckrodt Plc.; Molnlycke Health Care AB; 3M; Medtronic Plc.; Mimedx Group; Baxter Corporation |
| Customization & Pricing | Available upon Request |
By 2022 end, sales of regenerative artificial skin closed at a value of USD 2,185.5 Million
From 2016 to 2021, regenerative artificial skin demand expanded at a CAGR of 7%
From 2022 to 2032, regenerative artificial skin sales are expected to flourish at a CAGR of 9.9%
By 2032, the market value of regenerative artificial skin is expected to reach USD 5,615.5 Million
1. Executive Summary | Regenerative Artificial Skin Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2016 to 2021 and Forecast, 2022 to 2032 5. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Material Type 5.1. Temporary skin material 5.2. Single-layer material 5.3. Bi-layered material 5.4. Permanent Skin Material 5.5. Epidermal Skin Material 5.6. Dermal skin material 5.7. Composite skin material 5.8. Skin Graft 5.9. Allograft 5.10. Xenograft 5.11. Engineered skin material 6. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By End Use 6.1. Hospitals 6.2. Clinics 6.3. Burn care centers 7. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region 7.1. North America 7.2. Latin America 7.3. Europe 7.4. South Asia 7.5. East Asia 7.6. Oceania 7.7. Middle East and Africa (MEA) 8. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 9. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 10. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 11. South Asia Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 12. East Asia Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 13. Oceania Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 14. Middle East and Africa (MEA) Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Integra Life Sciences Corporation 17.2. Mylan N.V. 17.3. Johnson & Johnson Services 17.4. Smith & Nephew 17.5. Mallinckrodt plc. 17.6. Mölnlycke Health Care AB 17.7. 3M 17.8. Medtronic plc 17.9. Mimedx Group 17.10. Baxter Corporation 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Regenerative Artificial Skin Market
